claudin-6

News

Adding an mRNA vaccine to CAR-T cell therapy could be the key to unlocking activity in solid tumours, according to German biotech BioNTech

News

AstraZeneca has launched a cost-cutting programme that will aim to slash $1.5bn a year off its costs, with the savings reinvested in R&D.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.